Phreesia Inc (PHR)
18.60
+0.14
(+0.76%)
USD |
NYSE |
Nov 05, 16:00
18.60
0.00 (0.00%)
After-Hours: 20:00
Phreesia Enterprise Value: 984.70M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 984.70M |
| November 01, 2024 | 985.27M |
| October 31, 2024 | 974.88M |
| October 30, 2024 | 986.43M |
| October 29, 2024 | 978.92M |
| October 28, 2024 | 977.19M |
| October 25, 2024 | 972.56M |
| October 24, 2024 | 966.79M |
| October 23, 2024 | 981.23M |
| October 22, 2024 | 1.049B |
| October 21, 2024 | 1.051B |
| October 18, 2024 | 1.062B |
| October 17, 2024 | 1.097B |
| October 16, 2024 | 1.123B |
| October 15, 2024 | 1.133B |
| October 14, 2024 | 1.133B |
| October 11, 2024 | 1.131B |
| October 10, 2024 | 1.102B |
| October 09, 2024 | 1.127B |
| October 08, 2024 | 1.152B |
| October 07, 2024 | 1.153B |
| October 04, 2024 | 1.200B |
| October 03, 2024 | 1.193B |
| October 02, 2024 | 1.211B |
| October 01, 2024 | 1.210B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.235B |
| September 27, 2024 | 1.231B |
| September 26, 2024 | 1.201B |
| September 25, 2024 | 1.215B |
| September 24, 2024 | 1.245B |
| September 23, 2024 | 1.276B |
| September 20, 2024 | 1.281B |
| September 19, 2024 | 1.291B |
| September 18, 2024 | 1.308B |
| September 17, 2024 | 1.328B |
| September 16, 2024 | 1.331B |
| September 13, 2024 | 1.345B |
| September 12, 2024 | 1.291B |
| September 11, 2024 | 1.265B |
| September 10, 2024 | 1.283B |
| September 09, 2024 | 1.300B |
| September 06, 2024 | 1.279B |
| September 05, 2024 | 1.402B |
| September 04, 2024 | 1.315B |
| September 03, 2024 | 1.293B |
| August 30, 2024 | 1.404B |
| August 29, 2024 | 1.387B |
| August 28, 2024 | 1.350B |
| August 27, 2024 | 1.379B |
| August 26, 2024 | 1.419B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
458.61M
Minimum
May 11 2022
3.439B
Maximum
Nov 08 2021
1.478B
Average
1.233B
Median
Enterprise Value Benchmarks
| American Shared Hospital Services | 31.12M |
| Novo Integrated Sciences Inc | 4.018M |
| Astrana Health Inc | 2.392B |
| Cryo-Cell International Inc | 68.02M |
| P3 Health Partners Inc | 316.56M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.01M |
| Revenue (Quarterly) | 102.12M |
| Total Expenses (Quarterly) | 119.34M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | 67.87% |
| Profit Margin (Quarterly) | -17.64% |
| Earnings Yield | -9.68% |
| Normalized Earnings Yield | -9.677 |